← Back to patent-cliff list
CAS 1082040-43-4
methyl 6-fluoro-1H-indole-4-carboxylate
Codes: RUCA-019
Application context (from source-drug indications)
Prostate cancerRucaparib CamsylatePeritoneal cancerRucaparib CamsylateEpithelial ovarian cancerRucaparib CamsylateFallopian tube cancerRucaparib CamsylateOvarian cancerRucaparib CamsylateCastration-resistant prostate cancerRucaparib Camsylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rucaparib Camsylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(2,2-diethoxyethyl)isoindoline-1,3-dione→2-(1,3-dioxoisoindolin-2-yl)acetaldehyde→methyl 6-fluoro-1H-indole-4-carboxylate→methyl 3-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-6-fluoro-1H-indole-4-carboxylate→RUCA-021→RUCA-022→(4-formylphenyl)boronic acid→4-(8-fluoro-6-oxo-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-2-yl)benzaldehyde→(E)-8-fluoro-2-(4-((methylimino)methyl)phenyl)-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | Methyl 6-fluoro-1H-indole-4-carboxylate Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.